Introduction
Experimental
Results and Discussion
| No. | Compound | RIa | LRIb | % |
|---|---|---|---|---|
| 1 | Isobutyl isobutyrate | 908 | 908 | 0.2 |
| 2 | α-Thujene | 929 | 924 | 0.5 |
| 3 | α-Pinene | 938 | 932 | 1.3 |
| 4 | Camphene | 955 | 946 | 0.8 |
| 5 | Isoamyl propionate | 965 | 960 | 0.7 |
| 6 | Sabinene | 977 | 969 | 1.3 |
| 7 | β-Pinene | 984 | 974 | 0.6 |
| 8 | Butyl butanoate | 999 | 993 | 0.5 |
| 9 | Isoamyl isobutyrate | 1008 | 1007 | 0.8 |
| 10 | α-Terpinene | 1021 | 1014 | 2.1 |
| 11 | p-Cymene | 1029 | 1022 | 4.5 |
| 12 | Limonene | 1033 | 1024 | 0.8 |
| 13 | 1,8-Cineole | 1037 | 1026 | 4.8 |
| 14 | (Z)-β-Ocimene | 1046 | 1032 | 0.3 |
| 15 | Prenyl isobutyrate | 1049 | 1048 | 0.1 |
| 16 | Isopentyl butanoate | 1054 | 1052 | 0.5 |
| 17 | γ-Terpinene | 1063 | 1054 | 3.9 |
| 18 | cis-Sabinene hydrate | 1071 | 1065 | 1.2 |
| 19 | Terpinolene | 1093 | 1086 | 1.1 |
| 20 | Linalool | 1100 | 1095 | 1.5 |
| 21 | 2-Methyl butyl-2-methyl butyrate | 1102 | 1100 | 3.2 |
| 22 | cis-p-Menth-2-en-ol | 1128 | 1118 | 0.8 |
| 23 | Chrysanthenone | 1131 | 1124 | 0.8 |
| 24 | trans-p-Menth-2-en-ol | 1146 | 1136 | 0.7 |
| 25 | Camphor | 1155 | 1141 | 6.1 |
| 26 | Borneol | 1177 | 1165 | 3.6 |
| 27 | Terpinen-4-ol | 1189 | 1174 | 13.3 |
| 28 | α-Terpineol | 1198 | 1186 | 2.2 |
| 29 | Thymol, methyl ether | 1236 | 1232 | 0.2 |
| 30 | cis-Chrysanthenyl acetate | 1265 | 1261 | 0.2 |
| 31 | Lavandulyl acetate | 1286 | 1288 | 0.3 |
| 32 | Thymol | 1290 | 1289 | 1.1 |
| 33 | Terpinen-4-ol acetate | 1304 | 1299 | 0.8 |
| 34 | Neryl acetate | 1361 | 1359 | 0.3 |
| 35 | α-Copaene | 1390 | 1374 | 1.2 |
| 36 | (Z)-Jasmone | 1397 | 1392 | 1.1 |
| 37 | (E)-Caryophyllene | 1434 | 1417 | 0.5 |
| 38 | (E)-β-Farnesene | 1455 | 1454 | 0.5 |
| 39 | 7-1,2-dehydro-Sesquicineole | 1474 | 1471 | 0.3 |
| 40 | ar-Curcumene | 1488 | 1479 | 0.4 |
| 41 | Germacrene D | 1498 | 1484 | 1.3 |
| 42 | β-Selinene | 1504 | 1489 | 0.4 |
| 43 | Bicyclogermacrene | 1513 | 1500 | 0.8 |
| 44 | Sesquicineole | 1523 | 1515 | 1.4 |
| 45 | δ-Cadinene | 1535 | 1522 | 1.7 |
| 46 | (E)-Nerolidol | 1569 | 1561 | 14.5 |
| 47 | Longipinanol | 1579 | 1567 | 0.4 |
| 48 | Spathulenol | 1598 | 1577 | 2.2 |
| 49 | Caryophyllene oxide | 1604 | 1582 | 0.4 |
| 50 | allo-Aromadendrene epoxide | 1627 | 1639 | 0.6 |
| 51 | α -Muurolol | 1658 | 1640 | 1.7 |
| 52 | α-Cadinol | 1671 | 1652 | 3.2 |
| 53 | α-Bisabolol | 1693 | 1685 | 1.4 |
| 54 | Amorpha-4,9-dien-2-ol | 1706 | 1700 | 0.7 |
| Monoterpene hydrocarbons | 16.1 | |||
| Oxygenated monoterpenes | 39.0 | |||
| Sesquiterpene hydrocarbons | 7.9 | |||
| Oxygenated sesquiterpenes | 26.8 | |||
| Others | 6.1 | |||
| Total | 95.9 |
RI, retention indices relative to C6–C24 n-alkanes on the DB-5 column;
LRI, retention indices published in literature.
| Microorganism | MICa | IZb | |||
|---|---|---|---|---|---|
| Essential oil | Essential oil | Gentamicin | Ampicillin | Nystatine | |
| Bacillus subtilis | 1.8 | 25 ± 0.3 | nt | 14 ± 0.4 | nt |
| Enterococcus faecalis | 15 | 12 ± 0.4 | nt | 11 ± 0.3 | nt |
| Staphylococcus aureus | 3.75 | 18 ± 0.5 | nt | 13 ± 0.3 | nt |
| Staphylococcus epidermidis | 1.8 | 28 ± 0.3 | nt | 19 ± 0.5 | nt |
| Escherichia coli | 3.75 | 18 ± 0.2 | 23 ± 0.4 | nt | nt |
| Klebsiella pneumoniae | >15 | 10 ± 0.3 | 20 ± 0.4 | nt | nt |
| Pseudomonas aeruginosa | nt | - | 12 ± 0.3 | nt | nt |
| Candida albicans | >10 | 10 ± 0.3 | nt | nt | 18 ± 0.5 |
| Saccharomyces cerevisiae | 10 | 15 ± 0.6 | nt | nt | 18 ± 0.2 |
Minimum inhibitory concentration presented as mg/mL.
Inhibition zone includes diameter of disk (6 mm). Inactive (-);
| Cell lines | IC50 (μg/mL)a |
|---|---|
| Choriocarcinoma cell line (JET 3) | 1250 ± 6.9 |
| Human colon adenocarcinoma cell line (SW480) | 1250 ± 8.1 |
| Human breast cancer cell lines (MCF 7) | 625 ± 7.2 |
| Monkey kidney (Vero) | 312 ± 8.6 |
IC50 values were expressed as the mean±S.D., determined from the results of MTT assay in triplicate experiments.